AUG 29, 2020 10:04 AM PDT

Protecting the Heart Against Damage from Mechanical Stress

WRITTEN BY: Jasper Cantrell

Heart failure is a traumatic event that can have long-lasting consequences. Often, after an adverse cardiac event, the heart gets damaged, and the repair process isn’t always straightforward.

When it comes to the heart, any change is a big one. Some think that gaining muscle in the heart might make it stronger, but it actually makes it harder for it to beat. After a heart attack and other such events, the repair process can often leave extra muscle or other tissue. Protecting the heart from these changes is a critical area of research, and a team from the National Institutes of Natural Sciences in Japan wanted to help. Their new study investigated the role of a protein P2Y6R and how it could be targeted to protect the heart from muscle gain after mechanical stress damage.

P2Y6R is a purinergic receptor, a protein found at relatively high levels in the heart compared to the rest of the body. This family of receptors has a role in cardiac muscle growth and cardiac fibrosis. The team had previously worked on P2Y6R, and already know that its activation could suppress cardiac remodeling under pressure overload. They now hypothesized that if P2Y6R deficiency might suppress the negative cardiac muscle growth seen after mechanical stress.

They began simply by knocking out P2Y6R expression in a cell assay and examined what happened after simulating pressure overload. Cell damage and hypertrophy were significantly reduced in P2Y6R deficient group. With this positive data, they moved into a mouse model.

The team intended to examine how P2Y6R deficiency affected mice in simulated heart failure in the mouse model. Unfortunately, many P2Y6R deficient mice quickly died after heart failure simulation. Surviving P2Y6R deficient mice did show suppressed cardiac hypertrophy, however, consistent with previous experiments showing protective effects.

This study showed two very different results. In mice, P2Y6R deficiency had a high death rate, even though those that survived saw the expected results. However, cell assays showed no adverse effects. The team suggests it could have been several issues, ranging from the method of inducing the P2Y6R deficiency to the mode of P2Y6R activation. In vivo experiments can often go wrong, as one change can easily lead to a huge effect.

The study concludes, “In conclusion, although P2Y6R in cardiomyocytes definitely plays a key role in mechanical stress-induced cardiac remodeling, our results provide solid evidence that systemic inhibition of P2Y6R fails to prevent heart failure after pressure overload in mice.”

Sources: Nature Scientific Reports, khanacademymedicine

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
OCT 23, 2020
Clinical & Molecular DX
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
OCT 23, 2020
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
Cardiovascular disease is the leading cause of death globally, resulting in the loss of nearly 18 million lives each yea ...
NOV 24, 2020
Cardiology
Patients on Statins Get the 'Nocebo Effect'
NOV 24, 2020
Patients on Statins Get the 'Nocebo Effect'
Millions of people around the world take statins to treat high cholesterol, which are estimated to reduce the risk of he ...
DEC 10, 2020
Cardiology
CircRNAs as Prognostic Indicators for Atrial Fibrillation
DEC 10, 2020
CircRNAs as Prognostic Indicators for Atrial Fibrillation
The use of genetics in therapies and diagnostics has boomed over the decades. While many of these breakthroughs focus on ...
JAN 12, 2021
Cardiology
SGLT2 Inhibitors Can Reduce the Cardiovascular Risk for Diabetics Being Treated with Insulin
JAN 12, 2021
SGLT2 Inhibitors Can Reduce the Cardiovascular Risk for Diabetics Being Treated with Insulin
One of the biggest problems that come alongside diabetes is the increased risk of cardiovascular disease. Treatment of d ...
JAN 19, 2021
Cardiology
Looking to the Immune System for Help Diagnosing Carotid Stenosis
JAN 19, 2021
Looking to the Immune System for Help Diagnosing Carotid Stenosis
Everyone has seen a commercial about how bad fats can build up into a plaque into a blood vessel. This is called atheros ...
FEB 10, 2021
Cardiology
Finding the Link Between Air Pollution & Heart Disease
FEB 10, 2021
Finding the Link Between Air Pollution & Heart Disease
While many studies have shown that air pollution is linked to negative health impacts including poor cardiovascular heal ...
Loading Comments...